GetTopicDetailResponse(id=0094e582013, topicName=第二原發(fā)惡性腫瘤, introduction=第二原發(fā)惡性腫瘤, content=null, image=null, comments=2, allHits=1108, url=https://h5.medsci.cn/topic?id=75820, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=3630, tagList=[TagDto(tagId=3630, tagName=第二原發(fā)惡性腫瘤)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2251261, encodeId=22f5225126173, content=<a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=0094e582013' target=_blank style='color:#2F92EE;'>#第二原發(fā)惡性腫瘤#</a>, objectTitle=【柳葉刀子刊】成人AML強化治療后的非髓系第二原發(fā)腫瘤, objectType=article, longId=862544, objectId=37c686254402, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250207/1738927032520_8538692.jpg, objectUrl=/article/show_article.do?id=37c686254402, replyNumber=0, likeNumber=43, createdTime=2025-02-10, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=37c686254402, moduleTitle=【柳葉刀子刊】成人AML強化治療后的非髓系第二原發(fā)腫瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=37c686254402)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2227113, encodeId=2374222e11366, content=<a href='/topic/show?id=eff610e95796' target=_blank style='color:#2F92EE;'>#CAR-T 細胞#</a> <a href='/topic/show?id=0094e582013' target=_blank style='color:#2F92EE;'>#第二原發(fā)惡性腫瘤#</a> <a href='/topic/show?id=fa5689329c3' target=_blank style='color:#2F92EE;'>#血液系統(tǒng)惡性腫瘤#</a>, objectTitle=Clin Cancer Res：新研究表明CAR-T細胞治療后繼發(fā)性癌癥的風險可能與其他癌癥治療后的風險相似, objectType=article, longId=844365, objectId=ea3e84436547, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240922/1726982789985_2185383.png, objectUrl=/article/show_article.do?id=ea3e84436547, replyNumber=0, likeNumber=39, createdTime=2024-09-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=安徽省, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2216433, encodeId=692f221643330, content=<a href='/topic/show?id=0094e582013' target=_blank style='color:#2F92EE;'>#第二原發(fā)惡性腫瘤#</a> <a href='/topic/show?id=edba4069ec' target=_blank style='color:#2F92EE;'>#CAR-T治療#</a>, objectTitle=柳葉刀子刊：CAR-T治療后第二原發(fā)惡性腫瘤的特征,全球藥物警戒數(shù)據(jù)庫分析, objectType=article, longId=835877, objectId=fb898358e70e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240723/1721702745476_8538692.png, objectUrl=/article/show_article.do?id=fb898358e70e, replyNumber=0, likeNumber=138, createdTime=2024-07-23, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fb898358e70e, moduleTitle=柳葉刀子刊：CAR-T治療后第二原發(fā)惡性腫瘤的特征,全球藥物警戒數(shù)據(jù)庫分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fb898358e70e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1803720, encodeId=4bad1803e203d, content=<a href='/topic/show?id=0094e582013' target=_blank style='color:#2F92EE;'>#第二原發(fā)惡性腫瘤#</a>, objectTitle=AJH：治療和未治療的慢性淋巴細胞白血病患者的第二原發(fā)惡性腫瘤發(fā)生率對比, objectType=article, longId=218215, objectId=3d1e21821536, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d1e21821536, replyNumber=0, likeNumber=96, createdTime=2022-02-24, rootId=0, userName=ms7019579240139182, userId=84182500174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d1e21821536, moduleTitle=AJH：治療和未治療的慢性淋巴細胞白血病患者的第二原發(fā)惡性腫瘤發(fā)生率對比, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3d1e21821536)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803719, encodeId=d8451803e1961, content=<a href='/topic/show?id=0094e582013' target=_blank style='color:#2F92EE;'>#第二原發(fā)惡性腫瘤#</a>, objectTitle=Dig Dis Sci: 早發(fā)性大腸癌患者發(fā)生第二原發(fā)惡性腫瘤的風險增加, objectType=article, longId=211892, objectId=c1c3211892b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1c3211892b9, replyNumber=0, likeNumber=112, createdTime=2022-02-02, rootId=0, userName=ms7019579240139182, userId=84182500174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1c3211892b9, moduleTitle=Dig Dis Sci: 早發(fā)性大腸癌患者發(fā)生第二原發(fā)惡性腫瘤的風險增加, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c1c3211892b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
